(VIANEWS) – Shares of Merrimack Pharmaceuticals (NASDAQ: MACK) slid by a staggering 27.27% in 30 days from $5.83 to $4.24 at 11:17 EST on Wednesday, after two successive sessions in a row of losses. NASDAQ is rising 2.2% to $12,769.24, after three consecutive sessions in a row of losses.

Merrimack Pharmaceuticals’s last close was $4.16, 43.93% under its 52-week high of $7.41.


Today’s last reported volume for Merrimack Pharmaceuticals is 4374 which is 84.15% below its average volume of 27609.


Merrimack Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.63%, a negative 1.90%, and a positive 3.26%, respectively.

Merrimack Pharmaceuticals’s highest amplitude of average volatility was 1.56% (last week), 2.91% (last month), and 3.26% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Merrimack Pharmaceuticals’s stock is considered to be overbought (>=80).

Merrimack Pharmaceuticals’s Stock Yearly Top and Bottom Value

Merrimack Pharmaceuticals’s stock is valued at $4.24 at 11:17 EST, way under its 52-week high of $7.41 and way above its 52-week low of $3.66.

Merrimack Pharmaceuticals’s Moving Average

Merrimack Pharmaceuticals’s value is way below its 50-day moving average of $5.53 and way below its 200-day moving average of $5.26.

More news about Merrimack Pharmaceuticals (MACK).


Please enter your comment!
Please enter your name here